ANALYSIS OF DIABETES IN THE UK - INTRODUCTION - REUTERS BUSINESS INSIGHT - 2002/11/22 - TF Market Research

Report title: ANALYSIS OF DIABETES IN THE UK - INTRODUCTION

from TF Market Research
25 page report published Nov 22, 2002

Price $1,000.00 available for immediate download
This report is also available for purchase on a per-page basis.

Report Overview

Purchase by Section

About TF Market Research

Source:

REUTERS BUSINESS INSIGHT

Geographic Regions:

EUROPE, UNITED KINGDOM/GREAT BRITAIN/BRITISH ISLES, WESTERN EUROPE REGION

Industries:

BIOTECHNOLOGY, HEALTH CARE, PHARMACEUTICALS

Format:

PDF

Sections
	Title	Starting Page	Number of Pages
	CHAPTER 1 INTRODUCTION	1	3
	CURRENT AND FUTURE PREVALENCE OF DIABETES	4	1
	IMPACT OF DIABETES ON CARDIOVASCULAR RISK	6	1
	Mechanism of increased cardiovascular risk	6	1
	Insulin resistance syndrome	7	1
	DIABETES AND HYPERTENSION: A LETHAL COMBINATION	9	1
	Hypertension and insulin resistance	9	1
	Type 1 diabetics	9	1
	Type 2 diabetics	10	1
	Obesity	10	1
	Current and future prevalence of diabetic hypertension	11	1
	Prevalence of diabetic hypertension in the seven major markets 2001	11	1
	Increased risk associated with diabetic hypertension	12	1
	COMMERCIAL IMPLICATIONS	13	1
	Increased awareness of diabetes drives market growth	14	2
	Focus on diabetes prevention and CVD risk reduction	15	2
	COMPANIES TAKING THE LEAD	16	1
	ACE inhibitors and AIIRBs demonstrating renoprotection in type 1 and type 2 diabetics	16	1
	ACE inhibitor Altace (ramipril) demonstrating greater cardioprotection in type 2 diabetics	17	1
	Anti-obesity therapies trialed as adjunctive therapy for treatment of type 2 diabetes	17	2
	Novarits	18	1
	NAVIGATOR trial: Starlix (nateglinide) and Diovan (valsartan)	18	1
	Study protocol	18	1
	Expanding patient potential through early intervention	19	1
	Aventis	20	1
	DREAM trial: Altace (ramipril) and Avandia (rosiglitazone)	20	1
	GlaxoSmithKline	21	1
	Avandia (rosiglitazone) for the prevention of cardiovascular disease	21	1
	Clinical trials	21	1
	COMPANIES FACING UNEXPLOITED OPPORTUNITIES	22	1
	Takeda	23	1
	Sankyo	23	1
	Bristol-Myers Squibb	24	1
	AstraZeneca	24	1
	LOOKING AHEAD	25	1

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.

Price: $1,000.00

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Get FREE Research

Can't Decide?

Purchasing premium research sight unseen can be intimidating. We want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.